Janina Deutschmann

Dr. Janina Deutschmann

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in EMBO Reports
Verified
Journal Article
Open access
ARAlina Russ
Alina Russ
SWSabine Wittmann
Sabine Wittmann
YTYuta Tsukamoto
Yuta Tsukamoto
AHAlexandra Herrmann
Alexandra Herrmann
JDJanina Deutschmann
Janina Deutschmann
TGThomas Gramberg
Thomas Gramberg
Methylation of the mRNA 5′ cap by cellular methyltransferases enables efficient translation and avoids recognition by innate immune factors. Coronaviruses encode viral 2′‐O‐methyltransferases to shield their RNA from host factors. Here, we generate recombinant SARS–CoV‐2 harboring a catalytically inactive 2′‐O‐methyltransferase Nsp16, Nsp16mut, and analyze viral replication in human lung epithelial cells. Although replication is only slightly attenuated, we find SARS–CoV‐2 Nsp16mut to be highly immunogenic, resulting in a strongly enhanced release of type I interferon upon infection. The elevated immunogenicity of Nsp16mut is absent in cells lacking the RNA sensor MDA5. In addition, we report that Nsp16mut is highly sensitive to type I IFN treatment and demonstrate that this strong antiviral effect of type I IFN is mediated by the restriction factor IFIT1. Together, we describe a dual role for the 2′‐O‐methyltransferase Nsp16 during SARS–CoV‐2 replication in avoiding efficient recognition by MDA5 and in shielding its RNA from interferon‐induced antiviral responses, thereby identifying Nsp16 as a promising target for generating attenuated and highly immunogenic SARS–CoV‐2 strains and as a potential candidate for therapeutic intervention.

23 September 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
RBRamona Businger
Ramona Businger
JDJanina Deutschmann
Janina Deutschmann
IGIris Gruska
Iris Gruska
JMJens Milbradt
Jens Milbradt
LWLüder Wiebusch
Lüder Wiebusch
MSMichael Schindler
Michael Schindler

10 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BVBianca Volkmann
Bianca Volkmann
SWSabine Wittmann
Sabine Wittmann
JLJustine Lagisquet
Justine Lagisquet
JDJanina Deutschmann
Janina Deutschmann
KEKristin Eissmann
Kristin Eissmann
TGThomas Gramberg
Thomas Gramberg
Significance: LINE-1 retrotransposons are mobile genetic elements that have significantly contributed to the evolution of our genome. However, unhindered LINE-1 mobility can be detrimental and cause various genetic disorders. Here, we identify the antiviral protein TRIM5α as host factor that controls LINE-1 elements and protects our genome from novel insertions. In addition, we show that TRIM5α recognizes LINE-1 ribonucleoprotein complexes as a molecular pattern and initiates innate immune signaling upon sensing. Thus, our findings confirm the role of TRIM5α as pattern recognition receptor in innate immunity and uncover its important role in safeguarding the genome against endogenous mobile genetic elements.

2 March 2021 in Viruses
Verified
Journal Article
Open access
PDF file
JDJanina Deutschmann
Janina Deutschmann
TGThomas Gramberg
Thomas Gramberg
The SAM and HD domain-containing protein 1 (SAMHD1) is a dNTP triphosphohydrolase that plays a crucial role for a variety of different cellular functions. Besides balancing intracellular dNTP concentrations, facilitating DNA damage repair, and dampening excessive immune responses, SAMHD1 has been shown to act as a major restriction factor against various virus species. In addition to its well-described activity against retroviruses such as HIV-1, SAMHD1 has been identified to reduce the infectivity of different DNA viruses such as the herpesviruses CMV and EBV, the poxvirus VACV, or the hepadnavirus HBV. While some viruses are efficiently restricted by SAMHD1, others have developed evasion mechanisms that antagonize the antiviral activity of SAMHD1. Within this review, we summarize the different cellular functions of SAMHD1 and highlight the countermeasures viruses have evolved to neutralize the restriction factor SAMHD1.

23 September 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
JDJanina Deutschmann
Janina Deutschmann
ASAndrea Schneider
Andrea Schneider
IGIris Gruska
Iris Gruska
BVBarbara Vetter
Barbara Vetter
DTDominique Thomas
Dominique Thomas
TGThomas Gramberg
Thomas Gramberg

30 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SKStephan Klessing
Stephan Klessing
APAntonia Sophia Peter
Antonia Sophia Peter
KFKirsten Fraedrich
Kirsten Fraedrich
JWJannik Till Wagner
Jannik Till Wagner
MKMirko Kummer
Mirko Kummer
KÜKlaus Überla
Klaus Überla
Live-attenuated SARS-CoV-2 vaccines present themselves as a promising approach for the induction of broad mucosal immunity. However, for initial safety assessment in clinical trials, virus production requires conditions meeting Good Manufacturing Practice (GMP) standards while maintaining biosafety level 3 (BSL-3) requirements. Since facilities providing the necessary complex ventilation systems to meet both requirements are rare, we here describe a possibility to reproducibly propagate SARS-CoV-2 in the automated, closed cell culture device CliniMACS Prodigy® in a common BSL-3 laboratory. In this proof-of-concept study, we observed an approximately 300-fold amplification of SARS-CoV-2 under serum-free conditions with high lot-to-lot consistency in the infectious titers obtained. With the possibility to increase production capacity to up to 3000 doses per run, this study outlines a potential fast-track approach for the production of live-attenuated vaccine candidates based on highly pathogenic viruses under GMP-like conditions that may contribute to pandemic preparedness.